HIV- and cocaine-induced subclinical atherosclerosis

AIDS and Heart Disease

Volumn , Issue , 2004, Pages 257-268

  Lai, Shenghan ^a   Lima, João A C ^a   Meng, Qingyi ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868686118     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. Soodini G, Morgan JP. Can cocaine abuse exacerbate the cardiac toxicity of human immunodeficiency virus? Clin Cardiol 2001; 24:177-181.
2. Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med 2001; 94:384-390.
3. Passalaris JD, Sepkowitz KA, Glesby M. Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis 2000; 31:787-797.
4. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423-1430.
5. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus. Lancet 1999; 353:2893-2899.
6. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001; 104(3):257-262.
7. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351-358.
8. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine associated coronary vasospasm and thrombosis. J Am Coll Cardiol 1991; 17:1553-1560.
9. Simpson R, Edwards W. Pathogenesis of cocaine induced ischemic heart disease. Arch Pathol Lab Med 1986; 110:479-484.
10. Roh L, Hamele-Bena D. Cocaine-induced ischemic myocardial disease. Am J Forens Med Pathol 1990; 11:130-135.
11. Majid PA, Patel B, Kim HJ, Zimmerman JL, Dellinger RP. An angiographic and histologic study of cocaine-induced chest pain. Am J Cardiol 1990; 65:812-814.
12. Kolodgie FD, Wilson PS, Mergner WJ, Virmani R. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol 1999; 66(2): 109-122.
13. Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD, Chang SL, Kim KS, House SD, Weinand M, Witte M, Graves MC, Fiala M. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 1999; 91(1):68-76.
14. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwards RS. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plague burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31:126-133.
15. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K, and AHA staff. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation 1996; 94:1175-1192.
16. Anthony JC, Vlahov D, Celentano DD, Menon AS, Margolick JB, Cohn S, Nelson KE, Polk BF. Self-reported interview data for a study of HIV-1 infection among intravenous drug users:description of methods and preliminary evidence on validity. J Drug Issues 1991; 21(4):739-757.
17. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15(4):827-832.
18. SAS Institute, Inc. SAS/STAT User Guide. Version 8. Cary, NC: SAS Institute, Inc, 1999.
19. Muga R, Tor J, Rey-Joly C, Pardo A, Llobet P, Foz M. Dyslipemia and HIV-1 infection in intravenous drug addicts. Med Clin 1993; 100(5):161-163.
20. Ducobu J, Payen MC. Lipids and AIDS. Rev Med Brux 2000; 21(1):11-17.
21. Rogowska-Szadkowska D, Borzuchowska AK, Obserwacyjno ZB. The level of triglicerides, total cholesterol and HDL cholesterol in various stages of human immunodeficiency virus (HIV) infection. Pol Arch Med Wewn 1999; 101(2):145-150.
22. Mercie P, Tchamgoue S, Thiebaut R, Vialard JF, Faure I, Dancourt V, Marimoutou C, Dabis F, Rispal P, Darmon Y, Leng B, Pellegrin JL. Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome. Eur J Int Med 2000; 11(5):257-263.
23. Braun BL, Murray DM, Sidney S. Lifetime cocaine use and cardiovascular characteristics among young adults: the Cardia study. Am J Public Health 1997; 87(4):629-634.
24. Chen K, Scheier LM, Kandel DB. Effects of chronic cocaine use on physical health: a prospective study in a general population sample. Drug Alcohol Depend 1996; 43(1-2):23-37.
25. Fernandez-Miranda C, Pulido F, Carillo JL, Larumbe S, Gomez Izquierdo T, Ortuno B, Rubio R, del Palacio A. Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers. Clin Chim Acta 1998; 274(1):63-70.
26. Minor RL, Scott BD, Brown DD, Winniford MD. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991; 115:797-806.
27. Passalaris JD, Sepkowitz KA, Glesby MJ. Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis 2000; 31:787-797.
28. Tabib A, Leroux C, Mornex JF, Loire R. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients. Coron Artery Dis 2000; 11(1):41-46.
29. Flynn TE, Bricker LA. Myocardial infarction in HIV infected men receiving protease inhibitors. Ann Intern Med 1999; 131:548.
30. Margolin A, Avants SK, Setaro JF, Rinder HM, Grupp L. Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy? Drug Alcohol Depend 2000; 61:35-45.
31. Raggi P. Coronary calcium on electron beam tomography imaging as a surrogate maker of coronary artery disease. Am J Cardiol 2001; 87(suppl A):27A-34A.
32. Haberl R, Becker A, Knez A, Becker C, Lang C, Bruning R, Reiser M, Steinbeck G. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol 2001; 37(2):451-457.
33. Lower GDO, Yarnell, Rumley A, Bainton D, Sweetnam PM. C-reactive protein, fibrin Ddimer, and incident ischemic heart disease in the speedwell study. Arterioscler Thromb Vasc Biol 2001; 21:603-610.
34. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J. Chronic infections and the risk of carotid atherosclerosis. Circulation 2001; 103:1064-1071.
35. Ridker PM. High-sensitivity C-reactive protein. Potential adjunct for global risk assess ment in the primary prevention of cardiovascular disease. Circulation 2001; 103:1813-1821.
36. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol 1996; 156(4):1638-1645.
37. Lafrenie RM, Wahl LM, Epstein JS, Yamada KM, Dhawan S. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol 1997; 159(8):4077-4083.
38. Lai S, Lai H, Page JB, McCoy CB. The association between cigarette smoking and drug abuse in the United States. J Addict Dis 2000; 19(4): 11-24.